Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

AEA-[3siRNA-N-protein]-Glc nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

N-(15-azido-14,14-bis(azidomethyl)-3,6,9,12-tetraoxapentadecan)arachidonoylamide

Type Single Compound
Formula C33H56N10O5
Role core
2

siRNA

Type Biomolecule
Formula
Role layer
3

siRNA

Type Biomolecule
Formula
Role layer

Properties

Applications

Area Application Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Source
human T lymphocyte (Jurcat) cells infected with neurotropic rabies virus (RABV)

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • siRNA
  1. FdAF8bkcNobT0xztGqk
Product

AEA-[3siRNA-N-protein]-Glc nanoparticles

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • siRNA
  1. GBE7bdVBy3kb1zOOx51
Product

AEA-[3siRNA-N-protein]-Glc nanoparticles

Method 3

Type: Chemical synthesis
Source:
Starting materials
  • siRNA
  1. O0uWv1R9LVedWaFu4df
Product

AEA-[3siRNA-N-protein]-Glc nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial